You have 9 free searches left this month | for more free features.

City

Salt Lake City (1)

Seattle (1)

Condition

Anterior Segment Inflammation (1)

Corneal Graft Failure (1)

Corneal Neovascularization (1)

Immune-Mediated Necrotizing Myopathy (1)

Overall Status

Withdrawn (2)

Sign in for free

Phase

phase 1 (1)

phase 2 (1)

Sponsor

University of Utah (1)

University of Washington (1)

Collaborator

Grifols Biologicals, LLC (1)

Intervention

gamunex-c (2)

albumin (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Other (2)

Study Type

Interventional (2)

gamunex-c

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Immune-Mediated Necrotizing Myopathy Trial in Seattle (Gamunex-C, Albumin)

Withdrawn

Immune-Mediated Necrotizing Myopathy

Gamunex-C
Albumin

Seattle, Washington

University of Washington

Oct 19, 2022

Corneal Neovascularization, Corneal Graft Failure, Anterior Segment Inflammation Trial in Salt Lake City (Gamunex-C)

Withdrawn

Corneal Neovascularization
+2 more

Gamunex-C

Salt Lake City, Utah

John A. Moran Eye Center

Aug 3, 2016